Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Five Stocks Trading Higher Amid Positive News

The US stock markets have opened on a positive note today and keep trading in the green amid several interesting M&A deals.

Major indices are showing marginal gains as Allergan plc Ordinary Shares (NYSE:AGN) announced its acquisition of Vitae Pharmaceuticals Inc (NASDAQ:VTAE), while Mattress Firm Holding Corp (NASDAQ:MFRM) also reported the completion of a tender offer from Steinhoff International. In this article, we will take a closer look at these and other developments and will analyze the smart money sentiment towards the stocks in question.

At Insider Monkey, we track around 750 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see more details about our small-cap strategy).

investment, accounting, growth, bank, banking, concept, data, benefit, business, wealth, profit, rate, capital, trade, foreign, market, bill, chart, euro, world, background,


Shire PLC (ADR) (NASDAQ:SHPG) has reported the approval of its CUVITRU™ drug in adult and children over two years old by the US FDA. The drug is designed for treating patients with primary immunodeficiency. This condition affects up to six million people globally. With this approval, Shire now has the broadest portfolio of subcutaneous immunolglobulin (IG) and intravenous products, the company said in a statement. The treatment is already approved in Europe. A total of 64 of the funds we track hold about $3.77 billion of Shire PLC shares as of the end of June, up from 49 funds with stakes worth $2.57 billion at the end of March.

Follow Shire Plc
Trade (SHPGY) Now!

Mattress Firm Holding Corp (NASDAQ:MFRM) has just announced the successful completion of the tender offer proposed by Steinhoff International Holdings N.V, which involved the acquisition of 67.36% of Mattress Firm’s stock at $64.00 a share. Steinhoff, an integrated retailer that manufactures, sources and retails furniture and household goods, entered into an agreement to acquire Mattress Firm Holding Corp (NASDAQ:MFRM) back in August. A total of 15 funds we track amassed about $349 million worth of Mattress Firm shares at the end of June, down from 18 funds holding $459 million worth of stock a quarter earlier.

Follow Mattress Firm Holding Corp. (NASDAQ:MFRM)
Trade (NASDAQ:MFRM) Now!